OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
55
Views
1
CrossRef citations to date
0
Altmetric
Case Report
Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant
Zheng Zhao1 Third Department of Medical Oncology, Shannxi Provincial Cancer HospitalCorrespondence[email protected]
, Zhangjun Song2 Breast Surgery Center, Shannxi Provincial Cancer Hospital, Xi’an
, Xuwei Wang3 Marketing Department, Novogene Bioinformatics Institute, Beijing
, Haifeng Sun1 Third Department of Medical Oncology, Shannxi Provincial Cancer Hospital
, Xiaomin Yang2 Breast Surgery Center, Shannxi Provincial Cancer Hospital, Xi’an
, Yong Yuan4 Pathology Department, Shannxi Provincial Cancer Hospital, Xi’an, People’s Republic of China
& Pan Yu3 Marketing Department, Novogene Bioinformatics Institute, BeijingCorrespondence[email protected]
show all
Pages 4129-4133
|
Published online: 21 Aug 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.